A guide to normal iron metabolism, iron-related pathobiology, and the diagnosis and management of heritable and acquired iron overload disorders.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
James C. Barton is Medical Director, Southern Iron Disorders Center and Clinical Professor, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Inhaltsangabe
Foreword Preface 1. History of iron overload disorders 2. Normal iron absorption and metabolism 3. Iron toxicity 4. Tests for hemochromatosis and iron overload 5. Complications of hemochromatosis and iron overload 6. Insulin resistance and iron overload 7. Infections and immunity 8. Classical and atypical hfe hemochromatosis 9. Heterozygosity for hfe c282y 10. Porphyria cutanea tarda 11. Mitochondrial mutations as modifiers of hemochromatosis 12. Hemochromatosis associated with ferroportin gene (slc40a1) mutations 13. Hemochromatosis associated with hemojuvelin gene (hjv) mutations 14. Hemochromatosis associated with hepcidin gene (hamp) mutations 15. Hemochromatosis associated with transferrin receptor-2 gene (tfr2) mutations 16. Iron overload associated with ire mutation of ferritin heavy-chain gene (fth1) 17. Hereditary hyperferritinemia-cataract syndrome: ire mutations of ferritin light chain gene (ftl) 18. Iron overload in native Africans and African Americans 19. Hereditary atransferrinemia 20. Divalent metal transporter-1 (dmt1) iron overload 21. Iron overload associated with thalassemia syndromes 22. Iron overload associated with hemoglobinopathies 23. Iron overload associated with pyruvate kinase deficiency 24. Iron overload associated with congenital dyserythropoietic anemias 25. Hereditary sideroblastic anemias 26. Pearson marrow-pancreas syndrome 27. Acquired sideroblastic anemias 28. Hereditary aceruloplasminemia 29. Friedreich ataxia and cardiomyopathy 30. Pantothenate kinase (pank2)-associated neurodegeneration 31. Neuroferritinopathies 32. Gracile syndrome 33. Neonatal hemochromatosis 34. Iron overload due to excessive supplementation 35. Localized iron overload 36. Management of iron overload 37. Population screening for hemochromatosis 38. Ethical, legal, and social issues 39. Directions for future research Index.
Foreword Preface 1. History of iron overload disorders 2. Normal iron absorption and metabolism 3. Iron toxicity 4. Tests for hemochromatosis and iron overload 5. Complications of hemochromatosis and iron overload 6. Insulin resistance and iron overload 7. Infections and immunity 8. Classical and atypical hfe hemochromatosis 9. Heterozygosity for hfe c282y 10. Porphyria cutanea tarda 11. Mitochondrial mutations as modifiers of hemochromatosis 12. Hemochromatosis associated with ferroportin gene (slc40a1) mutations 13. Hemochromatosis associated with hemojuvelin gene (hjv) mutations 14. Hemochromatosis associated with hepcidin gene (hamp) mutations 15. Hemochromatosis associated with transferrin receptor-2 gene (tfr2) mutations 16. Iron overload associated with ire mutation of ferritin heavy-chain gene (fth1) 17. Hereditary hyperferritinemia-cataract syndrome: ire mutations of ferritin light chain gene (ftl) 18. Iron overload in native Africans and African Americans 19. Hereditary atransferrinemia 20. Divalent metal transporter-1 (dmt1) iron overload 21. Iron overload associated with thalassemia syndromes 22. Iron overload associated with hemoglobinopathies 23. Iron overload associated with pyruvate kinase deficiency 24. Iron overload associated with congenital dyserythropoietic anemias 25. Hereditary sideroblastic anemias 26. Pearson marrow-pancreas syndrome 27. Acquired sideroblastic anemias 28. Hereditary aceruloplasminemia 29. Friedreich ataxia and cardiomyopathy 30. Pantothenate kinase (pank2)-associated neurodegeneration 31. Neuroferritinopathies 32. Gracile syndrome 33. Neonatal hemochromatosis 34. Iron overload due to excessive supplementation 35. Localized iron overload 36. Management of iron overload 37. Population screening for hemochromatosis 38. Ethical, legal, and social issues 39. Directions for future research Index.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
